Arrhythmia risk in long QT syndrome: Beyond the disease-causative mutation

Circulation: Cardiovascular Genetics

Volumn 6, Issue 4, 2013, Pages 313-316

  Giudicessi, John R ^a   Ackerman, Michael J ^b,c  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

^c MAYO GRADUATE SCHOOL   (United States)

Author keywords

Editorials; Genetics; Ion channels; Long QT syndrome

Indexed keywords

ALLELE; CHROMOSOME; DISEASE SEVERITY; ELECTROCARDIOGRAM; FAINTNESS; GENE; GENE LOCUS; GENE MUTATION; GENETIC MARKER; GENETIC VARIABILITY; HAPLOTYPE; HEART ARRHYTHMIA; HEART RATE; HEART REPOLARIZATION; HUMAN; HUMAN GENOME; LONG QT SYNDROME; MODULATION; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; QT INTERVAL; REVIEW; RISK; SEIZURE;

EDITORIALS; GENETICS; ION CHANNELS; LONG QT SYNDROME;

FEMALE; HUMANS; KCNQ1 POTASSIUM CHANNEL; LONG QT SYNDROME; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84884514472     PISSN: 1942325X     EISSN: 19423268     Source Type: Journal    
DOI: 10.1161/CIRCGENETICS.113.000260     Document Type: Review

References (19)

1. Giudicessi JR, Ackerman MJ. Potassium-channel mutations and cardiac arrhythmias-diagnosis and therapy. Nat Rev Cardiol. 2012;9:319-332.
2. Tester DJ, Will ML, Haglund CM, Ackerman MJ. Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing. Heart Rhythm. 2005;2:507-517.
3. Kapplinger JD, Tester DJ, Salisbury BA, Carr JL, Harris-Kerr C, Pollevick GD, et al. Spectrum and prevalence of mutations from the first 2,500 consecutive unrelated patients referred for the FAMILION long QT syndrome genetic test. Heart Rhythm. 2009;6:1297-1303.
4. Giudicessi JR, Ackerman MJ. Determinants of incomplete penetrance and variable expressivity in heritable cardiac arrhythmia syndromes. Transl Res. 2013;161:1-14.
5. Vincent GM, Timothy KW, Leppert M, Keating M. The spectrum of symptoms and QT intervals in carriers of the gene for the long-QT syndrome. N Engl J Med. 1992;327:846-852.
6. Priori SG, Napolitano C, Schwartz PJ. Low penetrance in the long-QT syndrome: clinical impact. Circulation. 1999;99:529-533.
7. Priori SG, Schwartz PJ, Napolitano C, Bloise R, Ronchetti E, Grillo M, et al. Risk stratification in the long-QT syndrome. N Engl J Med. 2003;348:1866-1874.
8. Schouten EG, Dekker JM, Meppelink P, Kok FJ, Vandenbroucke JP, Pool J. QT interval prolongation predicts cardiovascular mortality in an apparently healthy population. Circulation. 1991;84:1516-1523.
9. Haugaa KH, Bos JM, Tarrell RF, Morlan BW, Caraballo PJ, Ackerman MJ. Institution-wide QT alert system identifies patients with a high risk of mortality. Mayo Clin Proc. 2013;88:315-325.
10. Lahtinen AM, Marjamaa A, Swan H, Kontula K. KCNE1 D85N polymorphism-A sex-specific modifier in type 1 long QT syndrome? BMC Med Genet. 2011;12:11.
11. Crotti L, Lundquist AL, Insolia R, Pedrazzini M, Ferrandi C, De Ferrari GM, et al. KCNH2-K897T is a genetic modifier of latent congenital long-QT syndrome. Circulation. 2005;112:1251-1258.
12. Viswanathan PC, Benson DW, Balser Jr. A common SCN5A polymorphism modulates the biophysical effects of an SCN5A mutation. J Clin Invest. 2003;111:341-346.
13. Makielski JC, Ye B, Valdivia CR, Pagel MD, Pu J, Tester DJ, et al. A ubiquitous splice variant and a common polymorphism affect heterologous expression of recombinant human SCN5A heart sodium channels. Circ Res. 2003;93:821-828.
14. Newton-Cheh C, Eijgelsheim M, Rice KM, de Bakker PI, Yin X, Estrada K, et al. Common variants at ten loci influence QT interval duration in the QTGEN study. Nat Genet. 2009;41:399-406.
15. Pfeufer A, Sanna S, Arking DE, Müller M, Gateva V, Fuchsberger C, et al. Common variants at ten loci modulate the QT interval duration in the QTSCD study. Nat Genet. 2009;41:407-414.
16. Crotti L, Monti MC, Insolia R, Peljto A, Goosen A, Brink PA, et al. NOS1AP is a genetic modifier of the long-QT syndrome. Circulation. 2009;120:1657-1663.
17. Tomás M, Napolitano C, De Giuli L, Bloise R, Subirana I, Malovini A, et al. Polymorphisms in the NOS1AP gene modulate QT interval duration and risk of arrhythmias in the long QT syndrome. J Am Coll Cardiol. 2010;55:2745-2752.
18. Duchatelet S, Crotti L, Peat RA, et al. Identification of a KCNQ1 polymorphism acting as a protective modifier against arrhythmic risk in long QT syndrome. Circ Cardiovasc Genet. 2013;6:354-361.
19. Amin AS, Giudicessi JR, Tijsen AJ, Spanjaart AM, Reckman YJ, Klemens CA, et al. Variants in the 3' untranslated region of the KCNQ1-encoded Kv7.1 potassium channel modify disease severity in patients with type 1 long QT syndrome in an allele-specific manner. Eur Heart J. 2012;33:714-723.